Samantha Moe's research while affiliated with College of Family Physicians of Canada and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (19)
Objective:
To determine the proportion of patients with neuropathic pain who achieve a clinically meaningful improvement in their pain with the use of different pharmacologic and nonpharmacologic treatments.
Data sources:
MEDLINE, EMBASE, the Cochrane Library, and a gray literature search.
Study selection:
Randomized controlled trials that rep...
Objective:
To summarize high-quality studies for 10 topics from 2020 that have strong relevance to primary care practice.
Selecting the evidence:
Study selection involved routine literature surveillance by a group of primary health care professionals. This included screening abstracts of high-impact journals and EvidenceAlerts, as well as search...
Objective:
To determine the proportion of chronic low back pain patients who achieve a clinically meaningful response from different pharmacologic and nonpharmacologic treatments.
Data sources:
MEDLINE, EMBASE, Cochrane Library, and gray literature search.
Study selection:
Published randomized controlled trials (RCTs) that reported a responder...
Objective:
To determine the effect of mask use on viral respiratory infection risk.
Data sources:
MEDLINE and the Cochrane Library.
Study selection:
Randomized controlled trials (RCTs) included in at least 1 published systematic review comparing the use of masks with a control group, either in community or health care settings, on the risk of...
Objective:
To determine how many patients with chronic osteoarthritis pain respond to various non-surgical treatments.
Data sources:
PubMed and the Cochrane Library.
Study selection:
Published systematic reviews of randomized controlled trials (RCTs) that included meta-analysis of responder outcomes for at least 1 of the following intervention...
Objectif: Résumer des études de qualité supérieure sur 10 sujets en 2018 qui sont étroitement en rapport avec la pratique des soins primaires. QUALITÉ DES DONNÉES: Pour choisir les études, un groupe de professionnels des soins de santé primaires a exercé une surveillance systématique des publications scientifiques, notamment par un examen des résum...
Objective:
To summarize high-quality studies for 10 topics from 2018 that have strong relevance to primary care practice.
Quality of evidence:
Study selection involved routine literature surveillance by a group of primary care health professionals. This included screening abstracts of important journals and Evidence Alerts, as well as searching...
Citations
... It should be noted that in addition to being supported only by low certainty of evidence and having numerous adverse events, with NNHs below NNTs, there was obvious heterogeneity in the types and doses of opioids used in the included trials. This, along with the potential risk of developing opioid use disorder with longer-term use, 22 makes clinical application challenging. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/273662272077857-1442257578576_Q64/G-Allan.jpg)
... The purpose of this set of systematic reviews was to assess the benefit and harms of the pharmacologic and nonpharmacologic therapies used in the management of neuropathic pain, specifically diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia in adults. Similar to our systematic reviews of osteoarthritis 8 and chronic low back pain, 9 we included only randomized controlled trials (RCTs) that reported a responder analysis-the proportion of patients who achieved a clinically meaningful improvement in pain. 10 This systematic review is the third in a series of reviews that will provide evidence for a guideline on the treatment of common chronic pain conditions in primary care. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/924118304174080-1597338381800_Q64/Joey-Ton.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/773761284460549-1561490474894_Q64/Betsy-Thomas-6.jpg)
... The efficacy of NSAIDs for OA-related pain has been demonstrated in several meta-analyses [63][64][65][66]. In one recent network meta-analysis of 76 trials of placebo, acetaminophen, and oral NSAIDs in 58,451 patients with OA of the knee or hip, for example, most NSAIDs examined improved both pain (effect sizes ranged from -0.05 to -0.63 across 19 arms) and function (effect sizes ranged from -0.03 to -0.53 across 18 arms) compared with placebo (effects sizes based on, or standardized to, a scale from 0 to 10) [63]. ...
... First, like osteoarthritis, FM is a very prevalent musculoskeletal condition. Currently, osteoarthritis is effectively managed at the primary care level [34,35]. Second, optimal patient management requires attention to the many symptom components, and an in-depth trusting conversation is essential to uncover psychological, cognitive and functional dimensions. ...
... You endorsed as valid, an "investigation" that was known by you to be a fraud, a vaccine promotional stunt, that was so corrupt that it had to be retracted within a few days of global publication. 16 But let us focus on Beta-coronavirus, specifically its history versus SARS-CoV-2 . . . as you are aware, the former SARS outbreak dates to 2003. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/930569177296902-1598876389551_Q64/Nicolas-Dugre.jpg)
... Let us scrutinize your hypocrisy, by way of contrast . . . 15 In stark contrast, in the current scenario, you have open hostility against low-cost treatments for COVID-19. You took the opposite tact; you derided the medical doctors involved; essentially condemned hydroxychloroquine treatments against SARS-CoV-2. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272435538821154-1441965102691_Q64/Scott-Garrison-2.jpg)
